Drug Insights

Expert Tips for Searching Ondansetron on Synapse

2 February 2024
2 min read

ZOFRAN® (Ondansetron Hydrochloride) is a medication used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and postoperative nausea and/or vomiting. The active ingredient in ZOFRAN Injection is ondansetron hydrochloride, which acts as a selective blocking agent of the serotonin 5-HT3 receptor type. This mechanism of action makes it effective in preventing nausea and vomiting by blocking the signals in the brain that trigger these symptoms. ZOFRAN Injection is a clear, colorless, nonpyrogenic, sterile solution for intravenous use. It was first approved by Novartis Pharmaceuticals Corp. in the United States in 1991. The pH of the injection solution ranges from 3.3 to 4.0. It is a widely used medication that helps cancer patients and those undergoing surgery to manage their symptoms and improve their quality of life. Click on the image below to begin the exploration journey of Ondansetron through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Navigating Health Information: How to Use Synapse to Search for Losartan
Drug Insights
2 min read
Navigating Health Information: How to Use Synapse to Search for Losartan
2 February 2024
Cozaar® (losartan potassium) is a drug for treating hypertension, left ventricular hypertrophy, and type 2 diabetes-related nephropathy.
Read →
Optimize Your Synapse Experience: A Step-by-Step Guide to Searching Melatonin
Drug Insights
2 min read
Optimize Your Synapse Experience: A Step-by-Step Guide to Searching Melatonin
1 February 2024
Melatonin is a small molecule drug that acts on melatonin receptors, functioning as an agonist.
Read →
CBR-701 (SYS6002): A Novel Nectin-4-Targeted Therapy Showing Promise in Initial Human Trials for Cancer Patients
Latest Hotspot
3 min read
CBR-701 (SYS6002): A Novel Nectin-4-Targeted Therapy Showing Promise in Initial Human Trials for Cancer Patients
1 February 2024
CBR-701 (SYS6002), a cutting-edge therapeutic agent aimed at Nectin-4, exhibits promising outcomes in initial human trials with Nectin-4 positive cancer patients.
Read →
The Synapse User's Toolkit: Tips for Searching Naproxen
Drug Insights
2 min read
The Synapse User's Toolkit: Tips for Searching Naproxen
1 February 2024
Naproxen is a small molecule drug that inhibits COX enzymes, with active indications including pain, gout, inflammation, ankylosing spondylitis, and juvenile arthritis.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.